💊#FDA Approval Update | #Awiqli (#insulin icodec), the first once-weekly basal insulin approved for #T2D
💉365→52 injections/year
📊To improve long-term glycemic control
🧪We offer insulin icodec for research use only: www.medchemexpress.com/insulin-icod...
www.medchemexpress.com/disease-area...
FDA Approves Novo Nordisk's Awiqli®: A New Era in Type 2 Diabetes Management #United_States #Novo_Nordisk #Plainsboro #Type_2_Diabetes #Awiqli
China NMPA Approves Icodec Insulin Injection(Awiqli) for Market Launch
📩 info@dengyuemed.com
🔗https://dengyuemed.com
#InsulinIcodec
#Awiqli
#NovoNordisk
#NMPAApproval
#ChinaDrugAdministration
#Type2Diabetes
#LongActingInsulin
#DiabetesTreatment
#PharmaceuticalNews
#2024DrugApprovals
Awiqli® (insulin icodec) pen. Courtesy of Novo Nordisk Canada.
Novo Nordisk has resubmitted Awiqli® (insulin icodec) to the FDA for type 2 diabetes, offering fewer injections and a simpler treatment routine.
jcst2d.com/index.php/ne...
#NovoNordisk #Awiqli #Type2Diabetes #Insulin #DiabetesResearch
oggi una svolta epocale...
inizio una nuova terapia insulinica basale che prevede una sola iniezione settimanale invece di una al giorno 🤩
le iniezioni ai pasti rimangono invariate, ma è già un grandissimo salto in avanti
La nuova insulina si chiama #Awiqli
@signorina37.bsky.social conoscevi?
Novo Nordisk Launches Awiqli Once-Weekly Insulin in Canada: Price Details epicnews.ca/canada/health/novo-nordi...
#Awiqli #Canada #diabetes #health #medicine #news #NovoNordisk